This is a Hong Kong news story, published by Yahoo Finance, that relates primarily to AstraZeneca news.
For more Hong Kong news, you can click here:
more Hong Kong newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
novel small molecule Lipoprotein. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest oral small molecule PCSK9 inhibitor AZD0780 news, density lipoprotein news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
CSPC Pharmaceutical Group LtdReuters
•79% Informative
AstraZeneca said it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd in an exclusive licence agreement.
The deal will boost the Anglo -Swedish drugmaker's cardiovascular pipeline.
Hong Kong -based company will get an upfront payment of $100 million as part of the deal.
VR Score
87
Informative language
92
Neutral language
61
Article tone
formal
Language
English
Language complexity
64
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links